Aristo Bio-Tech and Lifescience
NSE SME₹115,200 / 1600 Shares
Aristo Bio-Tech and Lifescience IPO Details
The Aristo Bio-Tech and Lifescience IPO price band is set between ₹72 per equity share, with a face value of ₹10 per share. The issue is managed by Link Intime India Private Ltd, and the equity shares are proposed to be listed on the NSE SME.
The IPO date for subscription opens on 16 Jan, 2023 and closes on 19 Jan, 2023. Investors can check the allotment status on 24 Jan, 2023, while the listing date is tentatively scheduled for 30 Jan, 2023.
The total issue size is 1,812,800 shares of ₹10, aggregating up to ₹13.05 Cr. Stay tuned for the latest Aristo Bio-Tech and Lifescience IPO review and GMP updates.
Aristo Bio-Tech and Lifescience IPO Review, Rating & Analysis
Aristo Bio-Tech and Lifescience IPO Review
NO REVIEWAristo Bio-Tech and Lifescience IPO Rating
Aristo Bio-Tech and Lifescience IPO Highlights
IPO Date
Jan 16, 2023 - Jan 19, 2023
Listing Date
30 Jan, 2023
Face Value
₹10 Per Equity Share
Price Band
₹72 per equity share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
NSE SME
Aristo Bio-Tech and Lifescience IPO Lot Size
The minimum market lot for Aristo Bio-Tech and Lifescience IPO is 1600 shares with an application amount of ₹1,15,200. Retail investors can apply for up to 1 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹1,15,200 |
| Retail (Max) | 1 | 1600 | ₹1,15,200 |
| S-HNI (Min) | 2 | 3200 | ₹2,30,400 |
| S-HNI (Max) | 8 | 12800 | ₹9,21,600 |
| B-HNI (Min) | 9 | 14400 | ₹10,36,800 |
Aristo Bio-Tech and Lifescience IPO Timeline
Issue Price
₹72 per equity shareFace Value
₹10 Per Equity ShareListing at Group
NSE SMERegistrar
Link Intime India Private LtdLead Manager
Beeline Capital Advisors Pvt LtdIssue Size
1,812,800 shares of ₹10(aggregating up to ₹13.05 Cr)Aristo Bio-Tech and Lifescience IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 30 Sep 22 | 10869.14 | 12907.49 | 258.9 | - | - | - |
| 31 Mar 22 | 7700.16 | 16603.29 | 146.17 | - | - | - |
| 31 Mar 21 | 8141.73 | 16722.96 | 107.57 | - | - | - |
| 31 Mar 20 | 8785.12 | 20123.94 | 100.74 | - | - | - |
All values are in ₹ Lakh
Promoters & Share Holding
Promoter(s) Name
- Mr. Narendra Singh Barhat
- Mrs. Kusum Narendra Singh Barhat
- Mr. Ketankumar Harkantbhai Joshi
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 100% | 73.37% |
About Company
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.
They deliver their products in India as well as engage in exporting products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators, and a wide variety of other Agrochemicals.
The industry Aristo Bio-Tech and Lifescience is engaged in, is a wide canvas full of possibilities where the entities deal in the production and distribution of pesticides and fertilizers. All these entities contribute towards enhancing crop yields and their quality.
Aristo Bio-Tech and Lifescience are delivering their products in over 20 states of India. Also, the offerings are extended to over 15 countries, including Armenia, Australia, Bangladesh, Belgium, Cambodia, Germany, Italy, Kenya, Moldova, New Zealand, Poland, South Africa, UAE, Ukraine, and Vietnam.
The company is ISO 9001: 2015 certified for their Quality Management System. Following are the products of Aristo:
Herbicides/Weedicides
Fungicides
Plant Growth Regulator
Insecticides
Alongside undertaking manufacturing operations, the company also provide Contract manufacturing, Job work and Toll manufacturing services for Crop Protection companies.
Aristo Bio-Tech and Lifescience IPO Subscription Details
| As on | QIB/NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 860,800 | 860,800 | 1,721,600 |
Day 1 -16-01-23 06:00 PM | 1.09 x | 3.24 x | 2.17 x |
Day 2 -17-01-23 06:00 PM | 3.45 x | 15.38 x | 9.41 x |
Day 3 -18-01-23 06:00 PM | 18.62 x | 44.14 x | 31.38 x |
Day 4 -19-01-23 06:00 PM | 285.84 x | 149.59 x | 217.72 x |
Frequently Asked Questions about Aristo Bio-Tech and Lifescience IPO
When will Aristo Bio-Tech and Lifescience IPO open for subscription?
The Aristo Bio-Tech and Lifescience IPO opens on 16 Jan, 2023 and closes on 19 Jan, 2023.
What is the investors portion for Aristo Bio-Tech and Lifescience IPO?
The investors' portion for QIB is , NII is N/A, and Retail is 860800.
How to apply for Aristo Bio-Tech and Lifescience IPO?
You can apply for Aristo Bio-Tech and Lifescience IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Aristo Bio-Tech and Lifescience IPO?
The issue size of Aristo Bio-Tech and Lifescience IPO is approx ₹1,812,800 shares of ₹10(aggregating up to ₹13.05 Cr) crores.
What is the price band of Aristo Bio-Tech and Lifescience IPO?
The price band for Aristo Bio-Tech and Lifescience IPO is ₹72 per equity share to ₹undefined.
What is the lot size of Aristo Bio-Tech and Lifescience IPO?
The minimum bid (lot size) for Aristo Bio-Tech and Lifescience IPO is N/A shares with an investment of approx ₹115,200 .
What is the allotment date of Aristo Bio-Tech and Lifescience IPO?
The allotment date for Aristo Bio-Tech and Lifescience IPO is 24 Jan, 2023.
What is the listing date of Aristo Bio-Tech and Lifescience IPO?
The listing date for Aristo Bio-Tech and Lifescience IPO is expected to be 30 Jan, 2023.
What is the GMP of Aristo Bio-Tech and Lifescience IPO?
The latest Grey Market Premium (GMP) for Aristo Bio-Tech and Lifescience IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.